Exploring Irish students’ attitudes towards nootropic supplements

References

• Alpha BRAIN®. (2022). Retrieved March 25, 2022, from https://www.onnit.com/alphabrain/
   Google Scholar
• Bandura, A. (1977). Social learning theory. Prentice Hall.
   Google Scholar
• Bell, S., Partridge, B., Lucke, J., & Hall, W. (2013). Australian University Students’ attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics, 6(1), 197–205. https://doi.org/10.1007/s12152-012-9153-9
   Web of Science ®Google Scholar
• Bergström, L. S., & Lynöe, N. (2008). Enhancing concentration, mood and memory in healthy individuals: An empirical study of attitudes among general practitioners and the general population. Scandinavian Journal of Public Health, 36(5), 532–537. https://doi.org/10.1177/1403494807087558
   PubMed Web of Science ®Google Scholar
• Bjønness, J. (2019). Gendered aspects of Danish students’ non-medical use of prescription pharmaceuticals for enhancement purposes in the ‘performance society. Drugs: Education, Prevention and Policy, 26(4), 309–318. https://doi.org/10.1080/09687637.2019.1590530
   Web of Science ®Google Scholar
• Brenninkmeijer, J., & Zwart, H. (2017). From ‘hard’ neuro-tools to ‘soft’ neuro-toys? Refocussing the neuro-enhancement debate. Neuroethics, 10(3), 337–348. https://doi.org/10.1007/s12152-016-9283-6
   PubMed Web of Science ®Google Scholar
• Byrne, M., Dick, S., Ryan, L., Dockray, S., Davoren, M., Heavin, C., Ivers, J. H., Linehan, C., & Vasiliou, V. (2022). The Drug Use in Higher Education in Ireland (DUHEI) Survey 2021: Main findings. University College Cork.
   Google Scholar
• Cavaco, A. M., Ribeiro, J., & Nørgaard, L. S. (2022). Exploring the use of cognitive enhancement substances among Portuguese university students. Exploratory Research in Clinical and Social Pharmacy, 5, 100097. https://doi.org/10.1016/j.rcsop.2021.100097
   PubMedGoogle Scholar
• Caviola, L., & Faber, N. S. (2015). Pills or push-ups? Effectiveness and public perception of pharmacological and non-pharmacological cognitive enhancement. Frontiers in Psychology, 6, 1852. https://doi.org/10.3389/fpsyg.2015.01852
   PubMed Web of Science ®Google Scholar
• Conrad, E. C., Humphries, S., & Chatterjee, A. (2019). Attitudes toward cognitive enhancement: The role of metaphor and context. AJOB Neuroscience, 10(1), 35–47. https://doi.org/10.1080/21507740.2019.1595771
   PubMedGoogle Scholar
• Coveney, C., & Bjønness, J. (2019). Making sense of pharmaceutical cognitive enhancement: Taking stock and looking forward. Drugs: Education, Prevention and Policy, 26(4), 293–300. https://doi.org/10.1080/09687637.2019.1618025
   Web of Science ®Google Scholar
• d'Angelo, L.-S C., Savulich, G., & Sahakian, B. J. (2017). Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. British Journal of Pharmacology, 174(19), 3257–3267. https://doi.org/10.1111/bph.13813
   PubMed Web of Science ®Google Scholar
• Dave, A. A., & Cabrera, L. Y. (2020). Osteopathic medical students’ attitudes towards different modalities of neuroenhancement: A pilot study. Journal of Cognitive Enhancement, 4(4), 422–433. https://doi.org/10.1007/s41465-020-00163-7
   Google Scholar
• Dempsey, R. C. (2021). Psychosocial motivators of “smart drug” use amongst university students. In M. Hall, M. Forshaw, & C. Montgomery (Eds.), Chemically modified minds: Substance use for cognitive enhancement. (pp. 13–34) Springer. https://doi.org/10.1007/978-981-15-6771-1_2
   Google Scholar
• DeSantis, A. D., & Hane, A. C. (2010). ‘Adderall is definitely not a drug’: Justifications for the illegal use of ADHD stimulants. Substance Use & Misuse, 45(1–2), 31–46. https://doi.org/10.3109/10826080902858334
   PubMed Web of Science ®Google Scholar
• Dresler, M., Sandberg, A., Bublitz, C., Ohla, K., Trenado, C., Mroczko-Wąsowicz, A., Kühn, S., & Repantis, D. (2019). Hacking the brain: Dimensions of cognitive enhancement. ACS Chemical Neuroscience, 10(3), 1137–1148. https://doi.org/10.1021/acschemneuro.8b00571
   PubMed Web of Science ®Google Scholar
• Dubljevic, V., & Ryan, C. (2015). Cognitive enhancement with methylphenidate and modafinil: Conceptual advances and societal implications. Neuroscience and Neuroeconomics, 2015(4), 25–33. https://doi.org/10.2147/NAN.S61925
   PubMedGoogle Scholar
• Enck, G. (2020). Virtues-based policies for pharmacological cognitive enhancement. AJOB Neuroscience, 11(4), 266–268. https://doi.org/10.1080/21507740.2020.1830870
   PubMedGoogle Scholar
• Fitz, N. S., Nadler, R., Manogaran, P., Chong, E. W. J., & Reiner, P. B. (2014). Public attitudes toward cognitive enhancement. Neuroethics, 7(2), 173–188. https://doi.org/10.1007/s12152-013-9190-z
   Web of Science ®Google Scholar
• Ford, J. A., & Pomykacz, C. (2016). Non-medical use of prescription stimulants: A comparison of college students and their same-age peers who do not attend college. Journal of Psychoactive Drugs, 48(4), 253–260. https://doi.org/10.1080/02791072.2016.1213471
   PubMed Web of Science ®Google Scholar
• Forlini, C., & Racine, E. (2012). Added stakeholders, added value(s) to the cognitive enhancement debate: Are academic discourse and professional policies sidestepping values of stakeholders? AJOB Primary Research, 3(1), 33–47. https://doi.org/10.1080/21507716.2011.645116
   Google Scholar
• Giurgea, C. (1973). The “nootropic” approach to the pharmacology of the integrative activity of the brain. Conditional Reflex: A Pavlovian Journal of Research & Therapy, 8(2), 108–115. https://doi.org/10.1007/BF03000311
   Google Scholar
• Grand View Research (2021). Global nootropics market size, share & growth. Retrieved February 22, 2020, from https://www.grandviewresearch.com/industry-analysis/nootropics-market?utm_source=prnewswire.com&utm_medium=referral&utm_campaign=PRN_Sep24_nootropics_CG_rd2&utm_content=Content
   Google Scholar
• Heyes, A. R., & Boardley, I. D. (2019). Psychosocial factors facilitating use of cognitive enhancing drugs in education: A qualitative investigation of moral disengagement and associated processes. Drugs: Education, Prevention and Policy, 26(4), 329–338. https://doi.org/10.1080/09687637.2019.1586831
   Web of Science ®Google Scholar
• Hupli, A., Didžiokaitė, G., & Ydema, M. (2016). Toward the smarter use of smart drugs: Perceptions and experiences of university students in the Netherlands and Lithuania. Contemporary Drug Problems, 43(3), 242–257. https://doi.org/10.1177/0091450916660143
   Google Scholar
• Hyman, S. E. (2011). Cognitive enhancement: Promises and perils. Neuron, 69(4), 595–598. https://doi.org/10.1016/j.neuron.2011.02.012
   PubMed Web of Science ®Google Scholar
• Jwa, A. S. (2019). Regulating the use of cognitive enhancement: An analytic framework. Neuroethics, 12(3), 293–309. https://doi.org/10.1007/s12152-019-09408-5
   Web of Science ®Google Scholar
• King, E. R., Repa, L. M., & Garland, S. N. (2022). Factors associated with permissive attitudes of university students towards prescription medication misuse. Journal of Substance Use, 27(1), 98–106. https://doi.org/10.1080/14659891.2021.1905091
   Web of Science ®Google Scholar
• Kudlow, P., Treurnicht Naylor, N., Xie, B., & McIntyre, R. S. M. M. D. (2013). Cognitive enhancement in Canadian medical students. Journal of Psychoactive Drugs, 45(4), 360–365. https://doi.org/10.1080/02791072.2013.825033
   PubMed Web of Science ®Google Scholar
• Ilieva, I. P., & Farah, M. J. (2019). Attention, motivation, and study habits in users of unprescribed ADHD medication. Journal of Attention Disorders, 23(2), 149–162. https://doi.org/10.1177/1087054715591849
   Google Scholar
• Lamkin, M. (2012). Cognitive enhancements and the values of higher education. Health Care Analysis: Journal of Health Philosophy and Policy, 20(4), 347–355. https://doi.org/10.1007/s10728-012-0224-1
   PubMed Web of Science ®Google Scholar
• Lazuras, L., Ypsilanti, A., Lamprou, E., & Kontogiorgis, C. (2017). Pharmaceutical cognitive enhancement in Greek university students: Differences between users and non-users in social cognitive variables, burnout, and engagement. Substance Use & Misuse, 52(7), 950–958. https://doi.org/10.1080/10826084.2016.1267223
   PubMed Web of Science ®Google Scholar
• Liakoni, E., Schaub, M. P., Maier, L. J., Glauser, G.-V., & Liechti, M. E. (2015). The use of prescription drugs, recreational drugs, and “soft enhancers” for cognitive enhancement among Swiss Secondary School Students. PLOS One, 10(10), e0141289. https://doi.org/10.1371/journal.pone.0141289
   PubMed Web of Science ®Google Scholar
• London-Nadeau, K., Chan, P., & Wood, S. (2019). Building conceptions of cognitive enhancement: University students’ views on the effects of pharmacological cognitive enhancers. Substance Use & Misuse, 54(6), 908–920. https://doi.org/10.1080/10826084.2018.1552297
   PubMed Web of Science ®Google Scholar
• Lopez Frias, F. J. (2021). “Fueling up” gamers. The ethics of marketing energy drinks to gamers. Neuroethics, 14(S2), 239–249. https://doi.org/10.1007/s12152-020-09442-8
   Google Scholar
• McCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. (2014). Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: Connecting the dots. Addictive Behaviors, 39(7), 1176–1182. https://doi.org/10.1016/j.addbeh.2014.03.008
   Google Scholar
• Maier, L. J., & Schaub, M. P. (2015). The use of prescription drugs and drugs of abuse for neuroenhancement in Europe: Not widespread but a reality. European Psychologist, 20(3), 155–166. https://doi.org/10.1027/1016-9040/a000228
   Web of Science ®Google Scholar
• Maier, L. J., Ferris, J. A., & Winstock, A. R. (2018). Pharmacological cognitive enhancement among non-ADHD individuals-A cross-sectional study in 15 countries. The International Journal on Drug Policy, 58, 104–112. https://doi.org/10.1016/j.drugpo.2018.05.009
   PubMed Web of Science ®Google Scholar
• Maier, L. J., Haug, S., & Schaub, M. P. (2015). The importance of stress, self-efficacy, and self-medication for pharmacological neuroenhancement among employees and students. Drug and Alcohol Dependence, 156, 221–227. https://doi.org/10.1016/j.drugalcdep.2015.09.012
   PubMed Web of Science ®Google Scholar
• Maier, L. J., Liakoni, E., Schildmann, J., Schaub, M. P., & Liechti, M. E. (2015). Swiss university students’ attitudes toward pharmacological cognitive enhancement. PLOS One, 10(12), e0144402. https://doi.org/10.1371/journal.pone.0144402
   PubMed Web of Science ®Google Scholar
• Maier, L. J., Liechti, M. E., Herzig, F., & Schaub, M. P. (2013). To dope or not to dope: Neuroenhancement with prescription drugs and drugs of abuse among Swiss University Students. PLOS One, 8(11), e77967. https://doi.org/10.1371/journal.pone.0077967
   PubMed Web of Science ®Google Scholar
• Mann, S. P., Deltoro, P., de, L., Cochrane, T., & Mitchell, C. (2018). Is the use of modafinil, a pharmacological cognitive enhancer, cheating? Ethics and Education, 13(2), 251–267. https://doi.org/10.1080/17449642.2018.1443050
   Web of Science ®Google Scholar
• Maslen, H., Faulmüller, N., & Savulescu, J. (2014). Pharmacological cognitive enhancement—how neuroscientific research could advance ethical debate. Frontiers in Systems Neuroscience, 8, 107. https://doi.org/10.3389/fnsys.2014.00107
   PubMedGoogle Scholar
• Maslen, H., Santoni de Sio, F., & Faber, N. (2015). With cognitive enhancement comes great responsibility?. In B.-J. Koops, I. Oosterlaken, H. Romijn, T. Swierstra, & J. van den Hoven (Eds.), Responsible innovation 2. (pp. 121–138). https://doi.org/10.1007/978-3-319-17308-5_7
   Google Scholar
• Mayor, E., Daehne, M., & Bianchi, R. (2019). How perceived substance characteristics affect ethical judgement towards cognitive enhancement. PLOS One, 14(3), e0213619. https://doi.org/10.1371/journal.pone.0213619
   PubMed Web of Science ®Google Scholar
• Mazanov, J., Dunn, M., Connor, J., & Fielding, M.-L. (2013). Substance use to enhance academic performance among Australian university students. Performance Enhancement & Health, 2(3), 110–118. https://doi.org/10.1016/j.peh.2013.08.017
   Google Scholar
• McDermott, H., Lane, H., & Alonso, M. (2021). Working smart: The use of ‘cognitive enhancers’ by UK university students. Journal of Further and Higher Education, 45(2), 270–283. https://doi.org/10.1080/0309877X.2020.1753179
   Web of Science ®Google Scholar
• Meier, B. P., Dillard, A. J., & Lappas, C. M. (2019). Naturally better? A review of the natural-is-better bias. Social and Personality Psychology Compass, 13(8), e12494. https://doi.org/10.1111/spc3.12494
   Web of Science ®Google Scholar
• Moore, D. R., Burgard, D. A., Larson, R. G., & Ferm, M. (2014). Psychostimulant use among college students during periods of high and low stress: An interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addictive Behaviors, 39(5), 987–993. https://doi.org/10.1016/j.addbeh.2014.01.021
   PubMed Web of Science ®Google Scholar
• Neurohacker Collective Pilot Study: Qualia Mind. (2018). Neurohacker collective. Retrieved 14 December 2020, from https://neurohacker.com/qualia-mind-pilot-study
   Google Scholar
• Nichols, A. L., & Maner, J. K. (2008). The good-subject effect: Investigating participant demand characteristics. The Journal of General Psychology, 135(2), 151–165. https://doi.org/10.3200/GENP.135.2.151-166
   PubMed Web of Science ®Google Scholar
• Nordberg, A. (2015). Patentability of methods of human enhancement. Journal of Intellectual Property Law & Practice, 10(1), 19–28. https://doi.org/10.1093/jiplp/jpu203
   Google Scholar
• O’Connor, C. (2019). Enhancing young brains in contemporary family life: Exploring the context and scope of pediatric neuro-enhancement. In S. K. Nagel (ed.), Shaping Children. (pp. 105–121). Springer.
   Google Scholar
• O'Connor, C., & Joffe, H. (2015). How the public engages with brain optimization: The media-mind relationship. Science, Technology & Human Values, 40(5), 712–743. https://doi.org/10.1177/0162243915576374
   PubMed Web of Science ®Google Scholar
• O’Connor, C., & Nagel, S. K. (2017). Neuro-enhancement practices across the lifecourse: Exploring the roles of relationality and individualism. Frontiers in Sociology, 2, 1. https://doi.org/10.3389/fsoc.2017.00001
   Google Scholar
• Partridge, B. J., Bell, S. K., Lucke, J. C., Yeates, S., & Hall, W. D. (2011). Smart drugs “as common as coffee”: Media hype about neuroenhancement. PLOS One, 6(11), e28416. https://doi.org/10.1371/journal.pone.0028416
   PubMed Web of Science ®Google Scholar
• Partridge, B., Lucke, J., & Hall, W. (2014). If you’re healthy you don’t need drugs”: Public attitudes towards “brain doping” in the classroom and “legalised doping” in sport. Performance Enhancement & Health, 3(1), 20–25. https://doi.org/10.1016/j.peh.2014.03.001
   Google Scholar
• Petersen, M. A., & Petersen, T. S. (2019). Why prohibit study drugs? Drugs: Education, Prevention and Policy, 26(4), 356–364. https://doi.org/10.1080/09687637.2019.1573878
   Web of Science ®Google Scholar
• Petersen, M. A., Enghoff, O., & Demant, J. (2019). The uncertainties of enhancement: A mixed-methods study on the use of substances for cognitive enhancement and it’s unintended consequences. Performance Enhancement & Health, 6(3–4), 111–120. https://doi.org/10.1016/j.peh.2018.09.001
   Google Scholar
• Petersen, M. A., Nørgaard, L. S., & Traulsen, J. M. (2015a). Pursuing pleasures of productivity: University students’ use of prescription stimulants for enhancement and the moral uncertainty of making work fun. Culture, Medicine and Psychiatry, 39(4), 665–679. https://doi.org/10.1007/s11013-015-9457-4
   PubMed Web of Science ®Google Scholar
• Petersen, M. A., Nørgaard, L. S., & Traulsen, J. M. (2015b). Going to the doctor with enhancement in mind – An ethnographic study of university students’ use of prescription stimulants and their moral ambivalence. Drugs: Education, Prevention and Policy, 22(3), 201–207. https://doi.org/10.3109/09687637.2014.970517
   Web of Science ®Google Scholar
• Petersen, M. A., Petersen, I. L., Poulsen, C., & Nørgaard, L. S. (2021). # studydrugs–Persuasive posting on Instagram. The International Journal on Drug Policy, 95, 103100. https://doi.org/10.1016/j.drugpo.2020.103100
   PubMed Web of Science ®Google Scholar
• Ponnet, K., Tholen, R., De Bruyn, S., Wouters, E., Van Ouytsel, J., Walrave, M., & Van Hal, G. (2021). Students’ stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation. Drug and Alcohol Dependence, 218, 108410. https://doi.org/10.1016/j.drugalcdep.2020.108410
   PubMed Web of Science ®Google Scholar
• Rabipour, S., Andringa, R., Boot, W. R., & Davidson, P. S. R. (2018). What do people expect of cognitive enhancement? Journal of Cognitive Enhancement, 2(1), 70–77. https://doi.org/10.1007/s41465-017-0050-3
   Google Scholar
• Reiner, P. B. (2019). Experimental neuroethics. In S. K. Nagel (Ed.), Shaping children: Ethical and social questions that arise when enhancing the young. (pp. 75–83) Springer International Publishing. https://doi.org/10.1007/978-3-030-10677-5_6
   Google Scholar
• Robitaille, C., & Collin, J. (2016). Prescription psychostimulant use among young adults: A narrative review of qualitative studies. Substance Use & Misuse, 51(3), 357–369. https://doi.org/10.3109/10826084.2015.1110170
   PubMed Web of Science ®Google Scholar
• Sandberg, A., & Bostrom, N. (2006). Cognitive enhancement: A review of technology.
   Google Scholar
• Sattler, S., & Wiegel, C. (2013). Cognitive test anxiety and cognitive enhancement: The influence of students’ worries on their use of performance-enhancing drugs. Substance Use & Misuse, 48(3), 220–232. https://doi.org/10.3109/10826084.2012.751426
   PubMed Web of Science ®Google Scholar
• Sattler, S., Forlini, C., Racine, E., & Sauer, C. (2013a). Impact of contextual factors and substance characteristics on perspectives toward cognitive enhancement. PLOS One, 8(8), e71452. https://doi.org/10.1371/journal.pone.0071452
   PubMed Web of Science ®Google Scholar
• Sattler, S., Mehlkop, G., Graeff, P., & Sauer, C. (2014). Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: The influence of drug characteristics, social environment, and personal characteristics. Substance Abuse Treatment, Prevention, and Policy, 9(1), 8. https://doi.org/10.1186/1747-597X-9-8
   PubMed Web of Science ®Google Scholar
• Sattler, S., Sauer, C., Mehlkop, G., & Graeff, P. (2013b). The rationale for consuming cognitive enhancement drugs in university students and teachers. PLOS One. 8(7), e68821. https://doi.org/10.1371/journal.pone.0068821
   PubMed Web of Science ®Google Scholar
• Schanker, B. D. (2011). Neuroenhancement in a medicated generation: Overlooked uses of cognitive stimulants. AJOB Neuroscience, 2(4), 28–30. https://doi.org/10.1080/21507740.2011.620069
   Google Scholar
• Schelle, K. J., Faulmüller, N., Caviola, L., & Hewstone, M. (2014). Attitudes toward pharmacological cognitive enhancement—a review. Frontiers in Systems Neuroscience, 8, 53. https://doi.org/10.3389/fnsys.2014.00053
   PubMedGoogle Scholar
• Schelle, K. J., Olthof, B. M. J., Reintjes, W., Bundt, C., Gusman-Vermeer, J., & van Mil, A. C. C. M. (2015). A survey of substance use for cognitive enhancement by university students in the Netherlands. Frontiers in Systems Neuroscience, 9, 10. https://doi.org/10.3389/fnsys.2015.00010
   PubMed Web of Science ®Google Scholar
• Singh, I. (2013). Not robots: Children’s perspectives on authenticity, moral agency and stimulant drug treatments. Journal of Medical Ethics, 39(6), 359–366. https://doi.org/10.1136/medethics-2011-100224
   PubMed Web of Science ®Google Scholar
• Singh, I., Bard, I., & Jackson, J. (2014). Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLOS One. 9(10), e105969. https://doi.org/10.1371/journal.pone.0105969
   PubMed Web of Science ®Google Scholar
• Smith, M. E., & Farah, M. J. (2011). Are prescription stimulants ‘smart pills’? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, 137(5), 717–741. https://doi.org/10.1037/a0023825
   PubMed Web of Science ®Google Scholar
• Solomon, T. M., Leech, J., Murphy, C., DeBros, G., Budson, A., & Solomon, P. (2015). A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN® administered orally. Journal of the International Society of Sports Nutrition, 12(Suppl. 1), P54. https://doi.org/10.1186/1550-2783-12-S1-P54
   Google Scholar
• Stasio, M. J., Curry, K., Kelly, M., Sutton-Skinner,  & Glassman, M. D. (2008). Over-the-counter medication and herbal or dietary supplement use in college: Dose frequency and relationship to self-reported distress. Journal of American College Health, 56(5), 535–548. https://doi.org/10.3200/JACH.56.5.535-548
   PubMed Web of Science ®Google Scholar
• Steward, A., & Pickersgill, M. (2019). Developing expertise, customising sleep, enhancing study practices: Exploring the legitimisation of modafinil use within the accounts of UK undergraduate students. Drugs, 26(4), 347–355. https://doi.org/10.1080/09687637.2018.1555231
   PubMed Web of Science ®Google Scholar
• Suliman, N. A., Mat Taib, C. N., Mohd Moklas, M. A., Adenan, M. I., Hidayat Baharuldin, M. T., & Basir, R. (2016). Establishing natural nootropics: Recent molecular enhancement influenced by natural nootropic. Evidence-Based Complementary and Alternative Medicine, 2016, 4391375. https://doi.org/10.1155/2016/4391375
   PubMed Web of Science ®Google Scholar
• Vrecko, S. (2013). Just how cognitive is “cognitive enhancement”? On the significance of emotions in university students’ experiences with study drugs. AJOB Neuroscience, 4(1), 4–12. https://doi.org/10.1080/21507740.2012.740141
   PubMedGoogle Scholar
• Whetstine, L. M. (2015). Cognitive enhancement: Treating or cheating? Seminars in Pediatric Neurology, 22(3), 172–176. https://doi.org/10.1016/j.spen.2015.05.003
   PubMed Web of Science ®Google Scholar